{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:54:56Z","timestamp":1765382096398},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hereditary paraganglioma (PGL)-pheochromocytoma (PCC) syndrome is a genetic disorder caused by a mutation of the tumor suppressor gene <jats:italic toggle=\"yes\">SDHD<\/jats:italic> that results in a predisposition for head and neck PGLs and PCCs. We present a case of a 33-year-old woman where <jats:sup>18<\/jats:sup>F-FDG PET\/CT showed areas of increased uptake in both the adrenal and cervical regions, consistent with PCCs and PGLs, respectively. Further imaging revealed that PCCs were <jats:sup>123<\/jats:sup>I-MIBG avid, whereas the PGLs were <jats:sup>111<\/jats:sup>In-octreotide avid. This demonstrates the varying sensitivities of different imaging modalities in regard to neuroendocrine tumors and the potential for treatment using multiple targeted therapies.<\/jats:p>","DOI":"10.1097\/rlu.0000000000001841","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T20:40:37Z","timestamp":1505248837000},"page":"964-965","source":"Crossref","is-referenced-by-count":2,"title":["Multimodality Radionuclide Imaging in a Patient With Hereditary Paraganglioma-Pheochromocytoma Syndrome"],"prefix":"10.1097","volume":"42","author":[{"given":"So Y.","family":"Yim","sequence":"first","affiliation":[{"name":"From the *Emory University School of Medicine; and \u2020Division of Nuclear Medicine and Molecular Imaging, Department of Radiology & Imaging Sciences, and \u2021Division of Endocrinology, Department of Medicine, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria M.","family":"Moncayo","sequence":"additional","affiliation":[{"name":"From the *Emory University School of Medicine; and \u2020Division of Nuclear Medicine and Molecular Imaging, Department of Radiology & Imaging Sciences, and \u2021Division of Endocrinology, Department of Medicine, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Pasquel","sequence":"additional","affiliation":[{"name":"From the *Emory University School of Medicine; and \u2020Division of Nuclear Medicine and Molecular Imaging, Department of Radiology & Imaging Sciences, and \u2021Division of Endocrinology, Department of Medicine, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghuveer K.","family":"Halkar","sequence":"additional","affiliation":[{"name":"From the *Emory University School of Medicine; and \u2020Division of Nuclear Medicine and Molecular Imaging, Department of Radiology & Imaging Sciences, and \u2021Division of Endocrinology, Department of Medicine, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20231021","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","year":"2000","journal-title":"Science"},{"key":"bib2-20231021","first-page":"2061","article-title":"Frequent germ-line succinate dehydrogenase subunit D gene mutations in patients with apparently sporadic parasympathetic paraganglioma","volume":"8","year":"2002","journal-title":"Clin Cancer Res"},{"key":"bib3-20231021","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1210\/jc.2009-2214","article-title":"The use of functional imaging in a patient with head and neck paragangliomas","volume":"95","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"bib4-20231021","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","article-title":"Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography","volume":"104","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"bib5-20231021","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2967\/jnumed.111.098152","article-title":"Modern nuclear imaging for paragangliomas: beyond SPECT","volume":"53","year":"2012","journal-title":"J Nucl Med"},{"key":"bib6-20231021","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2009.03648.x","article-title":"New imaging approaches to phaeochromocytomas and paragangliomas","volume":"72","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib7-20231021","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1148\/rg.275065729","article-title":"Scintigraphic imaging of body neuroendocrine tumors","volume":"27","year":"2007","journal-title":"Radiographics"},{"key":"bib8-20231021","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/ERC-10-0175","article-title":"Expression of somatostatin receptors, dopamine D2 receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas","volume":"18","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"bib9-20231021","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.2967\/jnumed.107.047738","article-title":"111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas","volume":"49","year":"2008","journal-title":"J Nucl Med"},{"key":"bib10-20231021","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000381458","article-title":"Usefulness of somatostatin receptor scintigraphy (Tc-[HYNIC, Tyr3]-octreotide) and 123I-metaiodobenzylguanidine scintigraphy in patients with SDHx gene-related pheochromocytomas and paragangliomas detected by computed tomography","volume":"101","year":"2015","journal-title":"Neuroendocrinology"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201712000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T04:15:14Z","timestamp":1697861714000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201712000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001841","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}